Skip Navigation


NDT Advance Access originally published online on February 18, 2008
Nephrology Dialysis Transplantation 2008 23(7):2223-2227; doi:10.1093/ndt/gfm932
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/7/2223    most recent
gfm932v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nguyen, M. K.
Right arrow Articles by Kurtz, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, M. K.
Right arrow Articles by Kurtz, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Correction of hypervolaemic hypernatraemia by inducing negative Na+ and K+ balance in excess of negative water balance: a new quantitative approach

Minhtri K. Nguyen and Ira Kurtz

Department of Medicine, UCLA Medical Center, Los Angeles, CA, USA

Correspondence and offprint requests to: Minhtri K. Nguyen, Division of Nephrology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Room 7-155 Factor Building, Los Angeles, CA 90095, USA. Tel: +1-310-206-6741; Fax: +1-310-825-6309; E-mail: mtnguyen{at}mednet.ucla.edu



  Abstract

Background. Hypervolemic hypernatremia is caused by an increase in total exchangeable Na+ and K+ in excess of an increment in total body H2O (TBW). Unlike patients with hypovolemic or euvolemic hypernatremia, treatment needs to be targeted at correcting not only the elevated plasma Na+ concentration, but also there is an additional requirement to achieve negative H2O balance to correct the increment in TBW.

Methods. Correction of hypervolemic hypernatremia can be attained by ensuring that the negative Na+ and K+ balance exceeds the negative H2O balance. These seemingly conflicting therapeutic goals are typically approached by administering intravenous 5% Dextrose (IV D5W) and furosemide.

Results. Currently, there is no quantitative approach to predicting the volume of IV D5W (VIVF) that needs to be administered that satisfies these requirements. Therefore, based on the principle of mass balance and the empirical relationship between exchangeable Na+, K+, TBW, and the plasma Na+ concentration, we have derived a new equation which calculates the volume of IV D5W (VIVF) needed to lower the plasma Na+ concentration ([Na+]p1) to a targeted level ([Na+]p2) by achieving the desired amount of negative H2O balance (VMB): VIVF = {([Na+]p1 + 23.8) (TBW1) – ([Na+]p2 + 23.8)(TBW1 + VMB) + 1.03 ([E]input x Vinput – [E]output x Voutput – [E]urine (Vinput – Voutput – VMB))}/1.03 x [E]urine where [E] = [Na+ + K+] and input and output refer to non-infusate and non-renal input and output respectively.

Conclusion. This new formula is the first quantitative approach for correcting hypervolemic hypernatremia by achieving negative Na+ and K+ balance in excess of negative H2O balance.

Keywords: dysnatraemia; hypernatraemia; hypervolaemia; sodium

Received for publication: 7.11.07
Accepted in revised form: 17.12.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
T. Ring and C. Overgaard
Correcting hypervolaemic hypernatraemia
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3366 - 3366.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. K. Nguyen and I. Kurtz
Reply
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3367 - 3368.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.